Marché de l'informatique pour la découverte de médicaments 2022

Table of Content

1.Introduction

1.1.Market Introduction
1.2.Market Research Methodology
1.2.1.Research Process
1.2.2.Primary Research
1.2.3.Secondary Research
1.2.4.Data Collection Technique
1.2.5.Data Sources
1.3.Market Estimation Methodology
1.3.1.Limitations of the Study
1.4.Product Picture of Drug Discovery Informatics
1.5.Global Drug Discovery Informatics: Classification
1.6.Geographic Scope
1.7.Years Considered for the Study
1.8.Research Methodology in brief
1.9.Parent Market Overview
1.10. Overall Drug Discovery Informatics Market Regional Demand
1.11. Research Programs/Design
1.12. Market Breakdown and Data Triangulation Approach
1.13. Data Source
1.14. Secondary Sources
1.15. Primary Sources
1.16. Primary Interviews
1.17. Average primary breakdown ratio

2.Market Dynamics

2.1.Drivers
2.1.1.Drivers
2.2.Restraints
2.2.1.Restraints
2.3.Opportunity
2.3.1.Impact forces on market dynamics
2.3.2.Impact forces during the forecast years
2.4.Industry Value Chain
2.4.1.Upstream analysis
2.4.2.Downstream analysis
2.4.3.Distribution Channel
2.4.4.Direct Channel
2.4.5.Indirect Channel
2.5.Potential Customers
2.6.Manufacturing/Operational Cost Analysis
2.7.Pricing Analysis by Region
2.8.Key Technology Landscape
2.9.Regulatory Analysis
2.10. Porter\'s Analysis
2.10.1.Supplier Power
2.10.2.Buyer Power
2.10.3.Substitution Threat
2.10.4.Threat from New Entry
2.10.5.Competitive Rivalry
2.11. PESTEL Analysis
2.12. Political Factors
2.13. Economic Factor
2.14. Social Factors
2.15. Technological Factor
2.16. Environmental Factors
2.17. Legal Factor

3.Global Drug Discovery Informatics Market Segmentation, by Revenue (USD Billion), (2023-2030)

3.1.By Solution
3.1.1.Software
3.1.2.Services
3.1.2.1.Sequence and Target Data Analysis Platforms
3.1.2.2.Libraries and Database Preparation
3.1.2.3.Docking
3.1.2.4.Molecular Modeling
3.1.2.5.Others
3.2.By Workflows
3.2.1.Discovery Informatics
3.2.1.1.Lead Generation Informatics
3.2.1.2.Identification & Validation Informatics
3.2.1.3.Assay Development Informatics
3.2.2.Development Informatics
3.2.2.1.FHD Preparation
3.2.2.2.Lead Optimization
3.2.2.3.Phase IA Informatics
3.2.2.4.Phase IB /2 Informatics
3.3.By Mode
3.3.1.In-House Informatics
3.3.2.Outsourced Informatics
3.4.By End Use
3.4.1.Pharmaceutical Companies
3.4.2.Biotechnology Companies
3.4.3.Contract Research Organizations (CROs)
3.4.4.Others

4.Global Drug Discovery Informatics Market Overview, By Region

4.1. North America Market Revenue (USD Billion), by Countries, (2023-2030)
4.1.1. US
4.1.1.1.By Solution
4.1.1.2.By Workflows
4.1.1.3.By Mode
4.1.1.4.By End Use
4.1.2.Canada
4.1.3.Mexico
4.2.Europe Market Revenue (USD Billion), by Countries, (2023-2030)
4.2.1.France
4.2.2.UK
4.2.3.Germany
4.2.4.Spain
4.2.5.Russia
4.2.6.Italy
4.2.7.BENELUX
4.3.Asia Pacific Market Revenue (USD Billion), by Countries, (2023-2030)
4.3.1. China
4.3.2. Japan
4.3.3. Australia
4.3.4. South Korea
4.3.5. India
4.3.6. ASIAN
4.4.Latin America Market Revenue (USD Billion), by Countries, (2023-2030)
4.4.1. Brazil
4.4.2. Argentina
4.4.3. Chile
4.5.Middle East and Africa Market Revenue (USD Billion), by Countries, (2023-2030)
4.5.1.GCC
4.5.2.Turkey
4.5.3.South Africa

5.Global Drug Discovery Informatics Market Revenue: Competitive Analysis, 2021

5.1.Key strategies by players
5.2.Revenue (USD Billion and %), By manufacturers, 2022
5.3.Player Positioning by Market Players, 2022

6.Competitive Analysis

6.1.Clarivate Analytics
6.1.1.Business Overview
6.1.2.Business Financials (USD Billion)
6.1.3.Product Category, Type, and Specification
6.1.4.Main Business/Business Overview
6.1.5.Geographical Analysis
6.1.6.Recent Development
6.1.7.Swot Analysis
6.2.Certara
6.3.Infosys Ltd.
6.4.Agilent Technologies, Inc.
6.5.IBM
6.6.Dassault Systèmes
6.7.Boehringer Ingelheim International GmbH
6.8.Charles River Laboratories
6.9.Collaborative Drug Discovery, Inc.
6.10.Eurofins DiscoverX Products
6.11.GVK Biosciences
6.12.Jubilant Biosys
6.13.Selvita
6.14.Cognizant
6.15.Albany Molecular Research Inc. (Curia Global, Inc.)
6.16.Oracle
6.17.Accenture
6.18.Illumina, Inc.
6.19.PerkinElmer Inc.
6.20.OpenEye, Cadence Molecular Sciences
6.21.Schrödinger, Inc.

7.Market Research Findings & Conclusion
Disclaimer

Disclaimer